Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Medpace Holdings, Inc. Director's Dealing 2019

Sep 26, 2019

30442_dirs_2019-09-26_657b8f21-9a88-4c4f-9435-8cc74453c600.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Medpace Holdings, Inc. (MEDP)
CIK: 0001668397
Period of Report: 2019-09-24

Reporting Person: Medpace Investors, LLC (10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2019-09-24 Common Stock M 4313 $14.41 Acquired 7755438 Direct
2019-09-24 Common Stock M 2222 $14.41 Acquired 7757660 Direct
2019-09-24 Common Stock M 1851 $16.20 Acquired 7759511 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2019-09-24 Employee Stock Option (Right to Buy) $14.41 M 4313 Acquired 2021-06-10 Common Stock (4313) Direct
2019-09-24 Employee Stock Option (Right to Buy) $14.41 M 2222 Acquired 2021-07-07 Common Stock (2222) Direct
2019-09-24 Employee Stock Option (Right to Buy) $16.20 M 1851 Acquired 2022-03-31 Common Stock (1851) Direct

Footnotes

F1: The stock options subject to this exercise are fully vested and exercisable.